Mbx Biosciences Inc (MBX)

Feb 18, 2025, 8:00 AM EST - 4 days ago

MBX Biosciences to Participate in March Investor Conferences

Jan 7, 2025, 7:00 AM EST - 6 weeks ago

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

Nov 18, 2024, 8:00 AM EST - 3 months ago

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

Oct 28, 2024, 8:00 AM EDT - 4 months ago

MBX Biosciences to Participate in Upcoming November Investor Conferences

Sep 30, 2024, 8:00 AM EDT - 5 months ago

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

Sep 16, 2024, 4:05 PM EDT - 5 months ago

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 14, 2024, 5:00 AM EDT - 5 months ago

U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market

BCAX GLXG TDTH XCH ZBIO

Sep 13, 2024, 12:36 PM EDT - 5 months ago

MBX Biosciences shares surge 44% in blockbuster Nasdaq debut

Sep 12, 2024, 7:20 PM EDT - 5 months ago

MBX Biosciences raises $163.2 mln in US IPO

Sep 12, 2024, 7:11 PM EDT - 5 months ago

MBX Biosciences Announces Pricing of Initial Public Offering

Sep 9, 2024, 6:30 AM EDT - 5 months ago

MBX Biosciences Announces Launch of Initial Public Offering

Aug 23, 2024, 4:44 PM EDT - 6 months ago

MBX Biosciences IPO Registration Document (S-1)